![Pierre Gianello](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pierre Gianello
Directeur/Membre du Conseil chez
NYXOAH SA
Fortune : 37 270 $ au 30/06/2026
Profil
Pierre Gianello is the founder of SYnAbs SA, which was founded in 2015.
He is currently a Director at Brussels Life Science Incubator SA and a Director at Pig For Life SA. He is also a Non-Executive Director at Nyxoah SA since 2018.
Dr. Gianello's former positions include being a Director at BruCells NV and Fetus For Life.
He was also a Professor at Katholieke Universiteit Leuven from 1997 to 2011.
Dr. Gianello holds a doctorate degree from Université Catholique de Louvain.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NYXOAH SA 0,02% | 01/03/2026 | 21 560 ( 0,02% ) | 37 270 $ | 30/06/2026 |
Postes actifs de Pierre Gianello
| Sociétés | Poste | Début |
|---|---|---|
| NYXOAH SA | Directeur/Membre du Conseil | 27/03/2018 |
Brussels Life Science Incubator SA
 Brussels Life Science Incubator SA Real Estate DevelopmentFinance Leases laboratory and medical research spaces for businesses | Directeur/Membre du Conseil | - |
Pig For Life SA
 Pig For Life SA Agricultural Commodities/MillingProcess Industries Engages in breeding pigs | Directeur/Membre du Conseil | - |
Anciens postes connus de Pierre Gianello
| Sociétés | Poste | Fin |
|---|---|---|
Katholieke Universiteit Leuven
 Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2011 |
Fetus For Life | Directeur/Membre du Conseil | - |
SynAbs SA
 SynAbs SA BiotechnologyHealth Technology Engages in producing custom rat and guinea pig monoclonal antibodies for pharmaceutical, biotech and in vitro diagnostic companies | Fondateur | - |
BruCells NV
 BruCells NV Pharmaceuticals: MajorHealth Technology Develops therapeutic cancer vaccines | Directeur/Membre du Conseil | - |
Formation de Pierre Gianello
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
49
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Katholieke Universiteit Leuven
Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BruCells NV
BruCells NV Pharmaceuticals: MajorHealth Technology Develops therapeutic cancer vaccines | Health Technology |
Université Catholique de Louvain
 Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brussels Life Science Incubator SA
Brussels Life Science Incubator SA Real Estate DevelopmentFinance Leases laboratory and medical research spaces for businesses | Finance |
Nyxoah SA
 Nyxoah SA Medical SpecialtiesHealth Technology Manufactures neurostimulation devices for treating obstructive sleep apnea | Health Technology |
SynAbs SA
SynAbs SA BiotechnologyHealth Technology Engages in producing custom rat and guinea pig monoclonal antibodies for pharmaceutical, biotech and in vitro diagnostic companies | Health Technology |
Pig For Life SA
Pig For Life SA Agricultural Commodities/MillingProcess Industries Engages in breeding pigs | Process Industries |
Fetus For Life |
Choisissez Zonebourse 
